全文获取类型
收费全文 | 229篇 |
免费 | 13篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 22篇 |
妇产科学 | 1篇 |
基础医学 | 17篇 |
口腔科学 | 4篇 |
临床医学 | 20篇 |
内科学 | 50篇 |
皮肤病学 | 3篇 |
神经病学 | 26篇 |
特种医学 | 27篇 |
外科学 | 19篇 |
综合类 | 6篇 |
预防医学 | 13篇 |
眼科学 | 5篇 |
药学 | 14篇 |
中国医学 | 1篇 |
肿瘤学 | 14篇 |
出版年
2023年 | 4篇 |
2022年 | 2篇 |
2021年 | 3篇 |
2020年 | 6篇 |
2019年 | 4篇 |
2018年 | 7篇 |
2017年 | 5篇 |
2016年 | 4篇 |
2015年 | 7篇 |
2014年 | 3篇 |
2013年 | 11篇 |
2012年 | 5篇 |
2011年 | 10篇 |
2010年 | 8篇 |
2009年 | 9篇 |
2008年 | 8篇 |
2007年 | 8篇 |
2006年 | 6篇 |
2005年 | 7篇 |
2004年 | 10篇 |
2003年 | 5篇 |
2002年 | 7篇 |
2001年 | 8篇 |
2000年 | 4篇 |
1999年 | 4篇 |
1998年 | 16篇 |
1997年 | 12篇 |
1996年 | 12篇 |
1995年 | 10篇 |
1994年 | 4篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 6篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 2篇 |
排序方式: 共有243条查询结果,搜索用时 15 毫秒
91.
D. C. L. Mohren N. W. H. Jansen IJ. Kant 《International archives of occupational and environmental health》2010,83(5):553-561
Purpose
To investigate the impact of increasing age on the need for recovery (NFR) over time among day workers 相似文献92.
Efficacy and safety of 6 or 8 weeks of simeprevir,daclatasvir, sofosbuvir for HCV genotype 1 infection
下载免费PDF全文
![点击此处可从《Journal of viral hepatitis》网站下载免费的PDF全文](/ch/ext_images/free.gif)
M. S. Sulkowski J. J. Feld E. Lawitz F. Felizarta A. M. Corregidor O. Khalid R. Ghalib W. B. Smith V. Van Eygen D. Luo L. Vijgen M. Gamil T. N. Kakuda S. Ouwerkerk‐Mahadevan P. Van Remoortere M. Beumont 《Journal of viral hepatitis》2018,25(6):631-639
The phase 2, open‐label ACCORDION (ClinicalTrials.gov: NCT02349048) study investigated the efficacy, safety and pharmacokinetics of a 6‐ or 8‐week regimen of simeprevir, daclatasvir and sofosbuvir in treatment‐naïve patients with chronic hepatitis C virus (HCV) genotype (GT) 1 infection and either early‐stage fibrosis or compensated cirrhosis. Patients were assigned to treatment groups according to their fibrosis stage. Early‐stage fibrosis: simeprevir 150 mg, daclatasvir 60 mg, sofosbuvir 400 mg once daily for 6 weeks; compensated cirrhosis: same regimen for 8 weeks. The primary endpoint was sustained virologic response 12 weeks after the end of treatment (SVR12). Safety, tolerability and pharmacokinetics of simeprevir, daclatasvir and sofosbuvir were investigated. Sixty‐eight patients were treated (6‐week group: n = 59; 8‐week group: n = 9). SVR12 was achieved by 86.4% (51/59) of patients with early‐stage fibrosis and by 100% (9/9) of patients with cirrhosis. The main reason for not achieving SVR12 in the 6‐week group was viral relapse (11.9%; 7/59). One patient had on‐treatment failure due to an early withdrawal (lost to follow‐up due to incarceration). One patient with SVR12 in the 6‐week group had a late viral relapse at post‐treatment week 24. No clinically significant drug‐drug interactions were observed. Adverse events were reported in 63.2% of patients (43/68) and were mainly grade 1/2. None of these led to treatment discontinuation. The 3 direct‐acting antiviral regimens of simeprevir, daclatasvir and sofosbuvir were safe and well tolerated in treatment‐naïve, HCV GT1‐infected patients with early‐stage fibrosis or compensated cirrhosis. 相似文献
93.
94.
Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force
下载免费PDF全文
![点击此处可从《Bipolar disorders》网站下载免费的PDF全文](/ch/ext_images/free.gif)
95.
目的探讨丹参通络解毒汤(DSTLJD)联合内皮祖细胞(endothelial progenitor cells, EPCs)移植对心肌缺血再灌注损伤(ischemic reperfusion injury, IRI)模型大鼠促血管新生作用的影响及其机制。方法采用密度梯度离心法及差数贴壁法分离和培养EPCs,采用免疫荧光法鉴定EPCs。通过结扎左冠状动脉左前降支的方法建立IRI模型,采用随机数字表法分为SH组(假手术组)、IRI组(模型组)、EPCs组(EPCs移植组)、DSTLJD组(丹参通络解毒汤组)、DSTLJD+EPCs组(丹参通络解毒汤+EPCs移植),每组10只。4周后,采用HE染色法观察心肌组织的病理形态,用免疫组化法测定各组大鼠心肌微血管计数(microvessel count, MVC)、心肌微血管密度(microvessel density, MVD),并检测各组大鼠血管内皮生长因子(vascular endothelial growth factor, VEGF)、碱性成纤维生长因子(basic fibroblast growth factor, bFGF)的蛋白表... 相似文献
96.
IJ Cohen L Kornreich S Mekhmandarov K Katz R Zaizov 《Archives of disease in childhood》1996,75(3):218-222
In type I Gaucher's disease, episodes of severe disabling bone pain, the so called bone crises, may be resistant to all analgesics, including narcotics. The demonstration of subperiosteal oedema on magnetic resonance imaging (MRI) led to an attempt to use steroids to relieve the oedema and thereby the pain. On eight occasions, five patients with documented bone crises received conventional dose steroids (20 mg/m2/day) with considerable shortening of the attacks. On six occasions five further patients received high dose methylprednisolone (30 mg/kg intravenously or 1 g/m2 orally daily for two days), which was followed by oral prednisone for three to five days on the last four occasions. In this later group, pain relief was evident within several hours. Three treatments were given on an ambulatory basis. The MRI scan of one of these patients showed no subperiosteal fluid collection five days after high dose steroids had been started, and on subsequent x ray examination, there was no periosteal elevation. This treatment should be considered in cases of Gaucher's disease with bone crises. 相似文献
97.
Keratoprosthesis results in animals: An update 总被引:1,自引:0,他引:1
CR Hicks FRCOphth X Lou PhD S Platten BSc AB Clayton PhD S Vijayasekaran MMedSci HJ Fitton PhD TV Chirila PhD FRACI GJ Crawford FRACO FRACS IJ Constable FRACO FRACS 《Clinical & experimental ophthalmology》1997,25(4):50-52
Background: The report presented is an update on continuing development work on modified PHEMA core-and-shirt KPros in animals. Methods: Two variations (improved wet-eye, and dry-eye) of a prototype core-and-skirt Chirila KPro are described. The clinical success rate on implantation of these versions of the Chirila KPro was assessed. Results: It was found that a significant improvement in retention rate was shown in the improved model but that the dry-eye model failed early in two of the three implanted. Conclusions: The significance of the improved strength and the reasons for disappointing results with the early dry-eye KPros are discussed. Ongoing work is briefly outlined. 相似文献
98.
R. J. Erdtsieck H. A. P. Pols N. K. Valk B. M. van Ouwerkerk S. W. J. Lamberts P. Mulder† J. C. Birkenhäger 《Clinical endocrinology》1995,43(5):557-565
OBJECTIVE It is known that growth hormone can Induce accelerated bone turnover in GH deficient people as well as healthy elderly people. In this study we examined the effect of recombinant human GH (rhGH) on bone mineral mass and bone turnover in the presence of the bone resorption inhibiting agent, pamidronate. Effects on body composition were also studied. METHODS Twenty-one post-menopausal osteoporotic women were treated with the bisphosphonate pamidronate during 12 months. During the Initial 6 months rhGH (0.0675 IU/kg, 3 times/week) was administered In a placebo controlled fashion (10 vs 11 patients). MEASUREMENTS Bone mineral Content (BMC) of the lumbar spine and femoral neck was measured with dual-energy X-ray absorptiometry and BMC of the distal and proximal forearm with single-photon absorptiometry. Body composition was measured with bioelectrical Impedance and total body dual-energy X-ray absorptiometry. Serum IGF-I and biochemical indices of bone turnover were also measured. RESULTS The group treated with rhGH showed a two to three-fold Increase In serum IGF-I levels. No effects on bone mineral mass were observed in the group treated with rhGH, either after the Initial 6 months of treatment with rhGH or after the total period of 12 months. In women treated with pamidronate, however, a consistent increase of about 5% at the lumbar spine and somewhat less in the distal forearm was reached from 6 months onwards. In neither group was any change observed in BMC at the femoral neck or forearm. Compared to baseline, the biochemical measurements of bone turnover showed a decrease of about 50% in the pamidronate treated group, but this effect was blunted in the group additionally treated with rhGH. The body composition measurements showed clear effects of rhGH administration: a decrease in fat mass of about 5% and an increase In lean body mass of about 3%. However, these effects disappeared after the treatment with rhGH was stopped and both fat mass and lean body mass returned to Initial values. CONCLUSIONS The present study suggests that treatment with rhGH blunted both the pamidronate induced accumulation of bone mineral mass and the reduction of biochemical markers of bone turnover. Furthermore, the positive effect of rhGH on body composition disappears completely after cessation of treatment with rhGH. 相似文献
99.
We have developed a polyacrylamide gradient gel electrophoretic method to quantitate apo-, mono-, and diferric transferrin based upon differences in their molecular size. Purified transferrin saturated to different extents (3% to 98%) with iron showed proportions of the three forms as predicted from an approximately random distribution of iron between the two metal-binding sites. The iron distributions in sera of 14 normal individuals similarly correlated with the predicted values. In contrast, 22 of 43 patients with diseases associated with abnormalities in iron or transferrin metabolism had a disproportionate increase in monoferric transferrin. This abnormality occurred in seven of nine patients who had received bone marrow transplants, seven of 14 with chronic liver disease, and eight of nine menstruating women with probable iron deficiency anemia. Interestingly, 11 patients with malabsorption or chronic renal disease had normal iron distributions. The finding of abnormal distributions of iron on transferrin suggests that gradient gel analysis may be a useful tool for studying the physiologic mechanisms controlling iron utilization. 相似文献
100.
In patients operated on for herniated lumbar disc, epidural morphine was administered intraoperatively at the end of the procedure. A 10 milligram dose of morphine provided significant pain relief expressed by less requirement for strong analgesics on the day of operation and the day following, as well as for sedatives during the postoperative observation period of four days in comparison to a control group of patients. The only side effect observed was urinary retention. 相似文献